ChrisChiuLab Profile Banner
Chris Chiu Profile
Chris Chiu

@ChrisChiuLab

Followers
952
Following
360
Media
0
Statuses
282

Clinician scientist working in flu and RSV, viruses that cause severe illness and death all around the world and still need effective vaccines.

London, England
Joined September 2015
Don't wanna be here? Send us removal request.
@MUSICCproject
MUSICC
1 year
Are you developing a next-generation SARS-CoV-2 vaccine? The MusiCC consortium are looking for vaccine developers who are interested in providing vaccine candidates for a COVID-19 human challenge study Find out more: https://t.co/ylGDWT6wY4
0
4
9
@ChrisChiuLab
Chris Chiu
1 year
Looking for an enthusiastic clinician interested in expanding their research experience working on exciting translational #covid19, #influenza & #rsv studies to develop better #vaccines!
1
0
2
@ChrisChiuLab
Chris Chiu
1 year
Looking for a great #research #nurse to join our team, working on world-leading studies of respiratory viral infections & #vaccines. All training given, so fantastic opportunity to develop new skills! Clinical Research Nurse at Imperial College London ( https://t.co/CMJHGwVTCR)
0
5
6
@ChrisChiuLab
Chris Chiu
2 years
Are you a #nurse looking for new challenges? Join our fantastic research team doing unique work on understanding #flu, #RSV and #COVID to develop better #vaccines! All relevant training given. More info at
0
6
18
@ChrisChiuLab
Chris Chiu
3 years
We are looking for healthy volunteers aged 30-55 to take part in a COVID-19 inhaled booster vaccine trial involving 12 visits over 12 months. You will be compensated up to £1,010 for your time. Contact flu-rsv-study@imperial.ac.uk   #WorldImmunisationWeek
4
28
30
@ChrisChiuLab
Chris Chiu
3 years
Looking to use your people and organisational skills to help with ground-breaking clinical research studies of #flu, #RSV and #SARS_CoV_2? Join our fantastic multi-disciplinary team!
Tweet card summary image
imperial.ac.uk
Join Imperial and be part of a world leading community of research, teaching and innovation.
0
2
6
@ChrisChiuLab
Chris Chiu
3 years
New year, new job?! Looking for a clinician interested in doing some cutting-edge infection research using #humanchallenge with #COVID19. Join a fantastic multi-disciplinary team doing something truly unique. For more info:
11
7
18
@ChrisChiuLab
Chris Chiu
3 years
Are you a clinician interested in #infection? Join our #multidisciplinary team working on #COVID19 #humanchallenge, performing unique research in a fantastic environment!
4
11
18
@p_openshaw
Peter Openshaw
3 years
Quote: "Based on the correlates of protection against new Omicron BA.4/5 infections, protection was lower and shorter after a third/booster vaccination, but higher and longer after breakthrough infection, especially among younger individuals."
@apsmunro
Alasdair Munro
3 years
Wonderful study from @drdavideyre et al using @ONS infection survey data After 2x vaccine, infection or booster vaccine increase protection vs BA.4/5 Waning is rapid after boosters but highly durable after infection Hybrid immunity is most durable https://t.co/DSUt7dBsHN
2
3
18
@ChrisChiuLab
Chris Chiu
3 years
Are you a #nurse looking to join a fantastic multidisciplinary #research team doing unique experimental medicine studies on #COVID19 and other #respiratory #viral #infections? Apply now! Deadline is tomorrow!
1
1
3
@ImperialMed
Imperial Medicine
3 years
How do you engage members of the public with medical research? In our latest Medicine blog, Dr Emma Smith, @hic_vac Network Manager, outlines how consulting the public was crucial during the world’s first #COVID-19 human challenge study. https://t.co/f5CgeMI8Gi
Tweet card summary image
blogs.imperial.ac.uk
How do you engage members of the public with medical research? Dr Emma Smith, HIC-Vac Network Manager, outlines how consulting the public was crucial during the world’s first COVID-19 human challenge...
0
5
10
@ImperialNHLI
NHLI
3 years
🎧 On this week’s @BBCRadio4's Inside Health, Dr Ryan Thwaites (@InThwaiteImmune) discusses what the options are for those who are immunocompromised and still vulnerable to the threat of Covid. From 11min.
Tweet card summary image
bbc.co.uk
The plight of the Covid-19 shielders.
0
6
11
@ChantsStudy
CHANTS study
3 years
Opening the second day of the @hic_vac meeting with a session on challenge models in a pandemic setting, excited to hear from @ChrisChiuLab reflecting on the SARS-CoV-2 model
0
4
11
@evelynekestelyn
Evelyne_Kestelyn
3 years
The role for human infection challenge models in #pandemic preparedness and beyond… @hic_vac 2022 annual meeting; 2 days of thought provoking discussions and presentations of cutting edge #research conducted #globally @khavie42 @OUCRU_Programme
0
4
15
@Covhic002Trial
COVHIC002
3 years
We are looking for healthy volunteers to take part in our COVHIC002 study. If you are aged 18-30, have been vaccinated against COVID-19 and you are in good health, visit: https://t.co/Xjs0ZzEKu8 to find out more. You will be paid up to £4,470 for your time and inconvenience.
Tweet card summary image
imperial.ac.uk
Imperial College London, in collaboration with Imperial College Healthcare NHS Trust and Chelsea and Westminster Hospital NHS Trust, and funded by the Wellcome Trust, are conducting a new human...
1
18
19
@ChrisChiuLab
Chris Chiu
3 years
My team is growing and we need #ResearchNurses to help with our unique #COVID #HumanChallenge studies! No research experience needed as we will train, but motivated teamplayers with solid clinical skills, please apply:
0
1
6
@NPR
NPR
3 years
Volunteers for the malaria trial put an arm over a box with hundreds of mosquitoes carrying a genetically modified malaria parasite. Here's why they did it that way — and why the trial holds promise.
12
31
98
@UKCICstudy
UK-CIC
3 years
Recent @UKCICstudy-supported work highlighting the need to develop vaccines that enhance nasal immunity 👇 https://t.co/QgbVELCIzN Nasal IgA wanes 9 months post-infection and is minimally impacted by subsequent vaccination. @p_openshaw @LanceTurtle @CCPUKstudy @InThwaiteImmune
2
8
11